Adverum Biotechnologies, Inc. (ADVM)
NASDAQ: ADVM · Real-Time Price · USD
6.17
-0.08 (-1.28%)
Nov 20, 2024, 4:00 PM EST - Market closed
Adverum Biotechnologies Revenue
Adverum Biotechnologies had revenue of $1.00M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $1.00M, down -72.22% year-over-year. In the year 2023, Adverum Biotechnologies had annual revenue of $3.60M.
Revenue (ttm)
$1.00M
Revenue Growth
-72.22%
P/S Ratio
105.43
Revenue / Employee
$8,264
Employees
121
Market Cap
128.35M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Puma Biotechnology | 243.57M |
Compugen | 59.85M |
Elutia | 24.78M |
Seer, Inc. | 14.61M |
Cardiff Oncology | 688.00K |
Zentek | 29.13K |
Inhibikase Therapeutics | 1.00 |
ADVM News
- 14 hours ago - Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 days ago - Adverum: Ixo-Vec Could Reduce Treatment Burden For Wet-AMD Patients - Seeking Alpha
- 5 days ago - Adverum Biotechnologies Announces Webcast to Report 52-Week LUNA Phase 2 Clinical Data and 4-Year OPTIC Clinical Data, and to Provide Key Pivotal Program Design Elements - GlobeNewsWire
- 16 days ago - Adverum Biotechnologies Reports Third Quarter 2024 Financial Results, Provides Corporate Highlights and Updates Anticipated Milestones - GlobeNewsWire
- 5 weeks ago - Adverum Biotechnologies Appoints Jason L. Mitchell as Chief Commercial Officer as it Prepares to Initiate Pivotal Program - GlobeNewsWire
- 2 months ago - Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Adverum Biotechnologies to Participate in Upcoming Fall Investor Conferences - GlobeNewsWire
- 3 months ago - Adverum Biotechnologies to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - GlobeNewsWire